Kenyon et al., 1999 - Google Patents
Analysis of the 5′ regulatory region of the human Norrie's disease gene: evidence that a non-translated CT dinucleotide repeat in exon one has a role in controlling …Kenyon et al., 1999
View PDF- Document ID
- 4329397236182689925
- Author
- Kenyon J
- Craig I
- Publication year
- Publication venue
- Gene
External Links
Snippet
Analysis of the 5′, upstream regions of the Norrie's disease gene (NDP) from 1380bp to+ 428 (relative to the putative transcription start site) has been undertaken by transfection analysis. Constructs in which a deletion series of sequences from the region were linked to a …
- 201000001929 Norrie disease 0 title abstract description 60
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gage et al. | Pituitary homeobox 2, a novel member of the bicoid-related family of homeobox genes, is a potential regulator of anterior structure formation | |
| Piras et al. | Zac1 (Lot1), a Potential Tumor Suppressor Gene, and the Gene for ɛ-Sarcoglycan Are Maternally Imprinted Genes: Identification by a Subtractive Screen of Novel Uniparental Fibroblast Lines | |
| Feng et al. | Cloning and characterization of the mouse AP-2ε gene: a novel family member expressed in the developing olfactory bulb | |
| Kameya et al. | Mfrp, a gene encoding a frizzled related protein, is mutated in the mouse retinal degeneration 6 | |
| Wang et al. | QRX, a novel homeobox gene, modulates photoreceptor gene expression | |
| Shore et al. | The human bone morphogenetic protein 4 (BMP-4) gene: molecular structure and transcriptional regulation | |
| Boda et al. | Survival motor neuron SMN1 and SMN2 gene promoters: identical sequences and differential expression in neurons and non-neuronal cells | |
| Grimm et al. | Isolation and embryonic expression of the novel mouse gene Hic1, the homologue of HIC1, a candidate gene for the Miller-Dieker syndrome | |
| Favor et al. | Relationship of Pax6 activity levels to the extent of eye development in the mouse, Mus musculus | |
| Kenyon et al. | Analysis of the 5′ regulatory region of the human Norrie’s disease gene: evidence that a non-translated CT dinucleotide repeat in exon one has a role in controlling expression | |
| LANGE et al. | Developmentally regulated mouse gene NK10 encodes a zinc finger repressor protein with differential DNA-binding domains | |
| US6475724B1 (en) | Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders | |
| AU720798B2 (en) | Regulators of UCP2 gene expression | |
| EP0876492B1 (en) | Novel methods for the characterization of compounds which stimulate stf-1 expression in pancreatic islet cells | |
| Saito et al. | Germ cell-specific expression of microphthalmia-associated transcription factor mRNA in mouse testis | |
| US6586581B1 (en) | Prolactin regulatory element binding protein and uses thereof | |
| Chang et al. | Structural characterization of the mouse Foxf1a gene | |
| KR20000057698A (en) | POLYPEPTIDES OF THE BASIC-HELIX-LOOP-HELIX bHLH FAMILY, CORRESPONDING NUCLEIC ACID SEQUENCES | |
| Wen et al. | Functional analysis of the promoter and chromosomal localization for human LEP503, a novel lens epithelium gene | |
| Hodges et al. | Characterization of the genomic and transcriptional structure of the CRX gene: substantial differences between human and mouse | |
| US20030129631A1 (en) | Gene family with transformation modulating activity | |
| US6197947B1 (en) | Translation initiation factor 4AIII and methods of use thereof | |
| JP4565702B2 (en) | Detection kit for detecting nucleic acid sequences whose expression is enhanced in human neuroblastoma with good prognosis in comparison with human neuroblastoma with good prognosis and poor prognosis | |
| US20040009505A1 (en) | Uses of the GJB6 gene for treating certain types of alopecia including the Clouston's syndrome, and for screening compounds capable of being efficient in the treatment of alopecia genetic susceptibility | |
| NUMAYAMA-TSURUTA et al. | The rat Small eye homozygote (rSey2/rSey2) can be regarded as a Pax6 null mutant |